|

Biotech surge: XBI ends correction and rallies as expected

The SPDR S&P Biotech ETF (XBI) draws investors who seek high-risk, high-reward exposure to the biotech sector. In late 2025, investor sentiment remains cautiously optimistic. This reflects both strong opportunities and ongoing uncertainty. Analysts set a 12-month price target near $141.31. That suggests a 48% upside from current levels around $95. Technical indicators support this outlook. Twelve out of seventeen signal “Buy,” and none recommend “Sell.” Still, some analysts urge caution. XBI depends on clinical trials and faces unpredictable earnings. Its volatility requires careful planning and strong risk tolerance.

Financial growth prospects for XBI look promising. Macroeconomic trends and biotech advances shape its performance. The industry expects gains from rising healthcare spending and aging populations. Breakthroughs in personalized medicine also support long-term growth. Investors remain hopeful about gene editing, immunotherapy, and rare disease treatments. However, they must manage risks from regulation and market swings. XBI offers strong growth potential but demands patience and a strategic mindset.

Elliott Wave structure: XBI weekly chart April 05th 2025

Chart

Months ago, we anticipated a correction in XBI. The market followed our forecast and confirmed both the expected decline and the reaction higher. Wave “a” formed a leading diagonal, ending at 86.40. Then, wave “b” peaked at 88.98, completing the corrective setup. Wave “c” of (II) triggered a strong decline into the 75.74–63.99 extreme zone for wave (II). We expected a response higher from this area to resume the rally. The Biotechnology sector reached this zone, validating our Elliott Wave analysis. Additionally, we noted that a break below 61.78 would open the path toward the 41.33–36.09 region.

Elliott Wave structure: XBI weekly chart September 09th 2025

Chart

In this latest update, we observe that wave (II) ended at the low of 66.66, right within the expected zone. The price then moved higher, aligning with our forecast. Currently, XBI trades at 94.98, delivering an impressive return of approximately 30%. We believe the price should continue rising to complete the impulsive structure as wave I. The final target for wave I remains uncertain, but we rely on the fractal structure to guide us. This helps us anticipate when a correction may begin, whether it unfolds in 3, 7, or even 11 swings, as part of wave II

Author

Elliott Wave Forecast Team

Elliott Wave Forecast Team

ElliottWave-Forecast.com

More from Elliott Wave Forecast Team
Share:

Editor's Picks

AUD/USD flirts with 0.7000, lowest since early August amid bullish USD

AUD/USD hits a fresh low since early August during the Asian session on Friday and looks vulnerable near 0.7000 after breaking below the 200-day SMA overnight. Against the backdrop of the hawkish Fed, a two-day rally in oil prices revives inflation fears and continues to push US bond yields to multi-year highs. Adding to this, geopolitical risks lift the US Dollar to a two-month high, overshadowing RBA rate hike bets and weighing on the pair.

USD/JPY pulls back from three-week high after failing near 159.00

USD/JPY edges lower during the Asian session on Friday, stalling its recent strong move to a three-week high of 159.00 as Japanese Yen bears turn cautious amid intervention fears. Meanwhile, the US Dollar retains a strong bullish undertone as the Fed's hawkish outlook and oil-driven inflation fears continue to push US bond yields to multi-year peaks. Furthermore, the BoJ's dovish rate hike last week might cap JPY and support spot prices.

Gold consolidates below $4,300 amid hawkish Fed, higher bond yields, and bullish USD

Gold extends its consolidative price move, and languishes near the weekly low set the previous day amid a bearish fundamental backdrop. The US Dollar pauses for a breather following a strong rally to a nearly two-month high and offers some support to the commodity. However, the US Federal Reserve's hawkish outlook, elevated US bond yields, and persistent geopolitical uncertainties favor USD bulls.

Ripple, Cardano, Solana: ETF inflows and whale demand signal further rally
Ripple (XRP), Cardano (ADA), and Solana (SOL) continue to experience a steady recovery with double-digit gains so far this month. Ripple and Solana experience firm institutional demand, while the percentage of ADA supply in profit rises, underpinned by interest from large-wallet investors, commonly referred to as whales.
Treasury yields at 2007 highs

The combination of energy prices rising back above $100 a barrel, US PMI’s topping multi-year indexes and FOMC members taking tough tones when discussing future rate paths have all led Treasuries at both ends of the curve with higher yields. Treasury Notes account for close to 52% of all marketable Treasuries, so movements in yields are especially painful for the US fiscal outlook.

BoJ Recap: Not as hawkish as expected

The Bank of Japan (BoJ) raised its short-term interest-rate target to 1.25% from 1.00% in a 7-2 vote, marking another step in the normalisation of monetary policy and widely matching what everyone has been expecting for weeks.